Search filters

List of works by Martin Hutchings

(18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study.

scientific article published on 20 November 2014

123 I-MIBG imaging for detection of anthracycline-induced cardiomyopathy

scientific article published on 2 March 2017

123I-MIBG for detection of subacute doxorubicin-induced cardiotoxicity in patients with malignant lymphoma

scientific article published on 19 December 2018

A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait.

scientific article published on 23 February 2015

A small change makes a big difference in Hodgkin lymphoma

scientific article published on 01 November 2018

Advances in the diagnosis and treatment of Hodgkin lymphoma and systemic anaplastic large cell lymphoma

Anti-CD30 antibody–drug conjugate therapy in lymphoma: current knowledge, remaining controversies, and future perspectives

Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial

Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study

scientific article published on 01 March 2020

Cancer mortality does not differ between migrants and Danish-born patients

scientific article

Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma

scientific article

Clinical presentation and staging of Hodgkin lymphoma

scientific article published on 13 May 2016

Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study

scientific article published on 09 April 2020

Concomitant semi-quantitative and visual analysis improves the predictive value on treatment outcome of interim 18F-fluorodeoxyglucose / Positron Emission Tomography in advanced Hodgkin lymphoma

scientific article

Depression and anxiety in Hodgkin lymphoma patients: A Danish nationwide cohort study of 945 patients

scientific article published on 17 April 2020

Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3

scientific article published on 21 December 2020

Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake.

scientific article published in September 2006

ESMO Consensus Conference on malignant lymphoma: management of 'ultra-high-risk' patients

scientific article published on 01 August 2018

ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia

scientific article published on 01 February 2018

Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial

scientific article published in June 2017

Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study

scientific article published on 23 July 2007

Early interim PET scan in Hodgkin lymphoma: where do we stand?

scientific article published on April 2008

Evaluation of Response After Radiotherapy for Hodgkin Lymphoma

scientific article published on 20 August 2010

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.

scientific article

FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma.

scientific article published on 24 June 2005

FDG-PET in the clinical management of Hodgkin lymphoma.

scientific article published in October 2004

FDG-PET response-adapted therapy: is 18F-fluorodeoxyglucose positron emission tomography a safe predictor for a change of therapy?

scientific article published on February 2014

FDG-PET/CT based response-adapted treatment.

scientific article

Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Diffuse Large B-cell Lymphoma

scientific article published on 30 July 2014

Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review

scientific article published on 09 March 2009

Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

scientific article published on 01 October 2018

Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

scientific article

How does PET/CT help in selecting therapy for patients with Hodgkin lymphoma?

scientific article published on January 1, 2012

Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial

scientific article published on 29 January 2018

Imaging in Lymphoma: The Key Role of Fluorodeoxyglucose-Positron Emission Tomography

scientific article (publication date: August 2015)

Imaging of non-Hodgkin lymphomas: diagnosis and response-adapted strategies.

scientific article published on January 2015

Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk

scientific article published on 07 December 2020

Impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvement

scientific article published on 24 February 2014

Improvements in Imaging of Hodgkin Lymphoma: Positron Emission Tomography

scientific article published on 01 September 2018

In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma

scientific article published on 28 July 2014

International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).

scientific article published on 3 April 2017

International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers.

scientific article

Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group

scientific article published on 20 January 2017

Little value of surveillance magnetic resonance imaging for primary CNS lymphomas in first remission: results from a Danish Multicentre Study.

scientific article published on 23 February 2016

Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials

scientific article published on 25 July 2020

New clues to the prognostic challenge of Hodgkin lymphoma

scientific article published on 19 November 2014

No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study.

scientific article published on 5 February 2016

Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.

scientific article published on 17 March 2014

Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma.

scientific article published on 11 August 2015

Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma

PET imaging in lymphoma ⬇️

scientific article published on June 1, 2009

PET-adapted treatment of Hodgkin lymphoma

scientific article published on 01 October 2019

PET/CT for Staging; Past, Present, and Future.

scientific article

PET/CT for therapy response assessment in lymphoma

scientific article published on 20 April 2009

PET/CT in the management of haematological malignancies

scientific article published on 12 February 2008

Phase 1 dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical Hodgkin lymphoma: the Transplant BRaVE study

scientific article published on 31 October 2018

Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.

scientific article

Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs.

scientific article

Pre-transplant positron emission tomography/computed tomography (PET/CT) in relapsed Hodgkin lymphoma: time to shift gears for PET-positive patients? ⬇️

scientific article published on July 18, 2011

Predictive value of PET response combined with baseline metabolic tumor volume in peripheral T-cell lymphoma patients.

scientific article published in September 2017

Prognostic impact of clinician-based interpretation of 18F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphoma.

scientific article published on 14 November 2013

Prognostic value of baseline metabolic tumor volume in early stage Hodgkin's lymphoma in the standard arm of H10 trial

scientific article published in February 2018

Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma.

scientific article published on 6 June 2005

Reply to B. Bennani-Baiti et al, H.J.A. Adams et al, E. Laffon et al, and E.A. Hawkes et al

scientific article published on 17 February 2015

Reply to G. Keramida et al.

scientific article published on 24 August 2015

Reply to H.J adams et al: "Is FDG-PET/CT a sensitive and specific method for the detection of extranodal involvement in diffuse large B-cell lymphoma?".

scientific article published on 17 November 2015

Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma.

scientific article published on 08 March 2017

Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.

scientific article published on September 2014

Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.

scientific article published on 24 February 2014

Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study

scientific article published on 5 October 2015

Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma

scientific article published on 13 November 2012

Routine follow-up scanning of patients with lymphoma: who, when, how, and why?

scientific article published in April 2011

Rubidium-82 positron emission tomography for detection of acute doxorubicin-induced cardiac effects in lymphoma patients

article

Survival differences between patients with Hodgkin lymphoma treated inside and outside clinical trials. A study based on the EORTC-Netherlands Cancer Registry linked data with 20 years of follow-up.

scientific article

Suspected Richter transformation: positron emission tomography/computed tomography tells us who should have a biopsy and where

scientific article

Targeted immunotherapy in Hodgkin lymphoma

scientific article published on 01 June 2015

The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy.

scientific article

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale

scientific article

The prognostic value of interim positron emission tomography scans combined with immunohistochemical data in diffuse large B-cell lymphoma.

scientific article published in December 2005

The role of bone marrow biopsy in Hodgkin lymphoma staging: “To be, or not to be, that is the question”? ⬇️

scientific article published on April 1, 2012

The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET/CT: a Danish-Canadian study

scientific article published on 21 March 2016

Treatment of Hodgkin lymphoma: the past, present, and future.

scientific article published on September 2008

Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma.

scientific article published on 21 February 2018

Uptake of FDG in Lemierre's syndrome with normal leucocyte scintigraphy.

scientific article published on 13 February 2003

Uterine, but not ovarian, female reproductive organ involvement at presentation by diffuse large B-cell lymphoma is associated with poor outcomes and a high frequency of secondary CNS involvement.

scientific article published on 29 September 2016

Utility of interim and end-of-treatment PET/CT in peripheral T-cell lymphomas: A review of 124 patients.

scientific article published on 22 July 2015

When and how to perform surveillance imaging in patients with lymphoma, and is it worth it?

scientific article published in June 2012

[Primary effusion lymphoma is a rare cause of pleural effusion] ⬇️

Paulina is supported by:

About Paulina

Help